HYDERABAD, India — Dr. Reddy’s Laboratories Ltd. will ring the Closing Bell at the New York Stock Exchange on May 29 to mark 25 years since its NYSE listing.
The company said its senior management team will attend the ceremony at the NYSE headquarters in New York City. Chairman Satish Reddy will lead the group, which also includes CEO Erez Israeli and other senior executives.
Dr. Reddy’s listed on the NYSE in April 2001, becoming the first pharmaceutical company in Asia, outside Japan, to do so. The company said the milestone reflects its long-term commitment to global governance, transparency and innovation.
“Twenty-five years on the NYSE is more than a listing anniversary; it is a reaffirmation of our commitment to global governance, transparency, and innovation,” Satish Reddy said.
The ceremony will be livestreamed on NYSE.com and the New York Stock Exchange YouTube channel.
Dr. Reddy’s, headquartered in Hyderabad, India, offers a portfolio that includes APIs, generics, branded generics, biosimilars and OTC products. Its major therapeutic areas include gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
